Bioxcel Therapeutics, Inc. (BTAI)

Trade BTAI now with
9/24/2018 7:02:00 AM BioXcel Therapeutics Expands Immuno-Oncology Partnership With Nektar Into Clinical Development In Pancreatic Cancer
6/7/2018 8:18:26 AM BioXcel Therapeutics Appoints Vincent O’Neill As SVP And Chief Medical Officer
6/4/2018 8:34:28 AM BTI, Nektar Present Preclinical Pancreatic Cancer Data For BXCL701, NKTR-214 & Anti-PD1 Combination Therapy
5/14/2018 4:04:04 PM BioXcel Therapeutics Q1 Loss/share $0.37 Vs. Loss $0.06 Year Ago